5AM Venture Management, LLC

5AM Venture Management, LLC reported 16 holdings worth US$297M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

5AM Venture Management, LLC reported 16 holdings worth US$297M as of Sep 30, 2026. Largest: Latigo Biotherapeutics, Inc., Entrada Therapeutics, Inc. and Tyra Biosciences, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
16
Value as reported
US$297M

The filing in full

CompanySharesValue as reported% of portfolio
Latigo Biotherapeutics, Inc.7.33MUS$122M41.2%
Entrada Therapeutics, Inc.3.78MUS$24M8.1%
Tyra Biosciences, Inc.1.03MUS$22.5M7.6%
CAMP4 Therapeutics Corporation5.28MUS$21.3M7.2%
Artiva Biotherapeutics, Inc.2.35MUS$16.8M5.6%
Tectonic Therapeutic, Inc.607KUS$14.1M4.8%
Celldex Therapeutics, Inc.422KUS$13.7M4.6%
Zentalis Pharmaceuticals, Inc.3.95MUS$10.9M3.7%
Biohaven Ltd.739KUS$9.87M3.3%
MapLight Therapeutics, Inc.742KUS$7.56M2.5%
Silence Therapeutics PLC476KUS$5.2M1.8%
ALX Oncology Holdings Inc.3.06MUS$4.25M1.4%
Protara Therapeutics, Inc.1.37MUS$4.18M1.4%
EyePoint, Inc.1.05MUS$3.43M1.2%
Skye Bioscience, Inc.0US$00.00%
Surrozen, Inc.0US$00.00%

Source

Download original · View original at SEC

Related